- Home
- LGVN vs SST Comparison
LGVN vs SST Comparison
Compare LGVN & SST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LGVN
- SST
- Stock Information
- Founded
- LGVN 2014
- SST 2013
- Country
- LGVN United States
- SST United States
- Employees
- LGVN N/A
- SST N/A
- Industry
- LGVN Medicinal Chemicals and Botanical Products
- SST Diversified Commercial Services
- Sector
- LGVN Health Care
- SST Consumer Discretionary
- Exchange
- LGVN Nasdaq
- SST Nasdaq
- Market Cap
- LGVN 23.4M
- SST 23.3M
- IPO Year
- LGVN 2021
- SST N/A
- Fundamental
- Price
- LGVN $1.31
- SST $6.04
- Analyst Decision
- LGVN Strong Buy
- SST Strong Buy
- Analyst Count
- LGVN 3
- SST 1
- Target Price
- LGVN $8.67
- SST $500.00
- AVG Volume (30 Days)
- LGVN 134.8K
- SST 343.4K
- Earning Date
- LGVN 08-13-2025
- SST 08-07-2025
- Dividend Yield
- LGVN N/A
- SST N/A
- EPS Growth
- LGVN N/A
- SST N/A
- EPS
- LGVN N/A
- SST N/A
- Revenue
- LGVN $2,225,000.00
- SST $333,521,000.00
- Revenue This Year
- LGVN N/A
- SST N/A
- Revenue Next Year
- LGVN $51.48
- SST $8.39
- P/E Ratio
- LGVN N/A
- SST N/A
- Revenue Growth
- LGVN 127.50
- SST N/A
- 52 Week Low
- LGVN $1.14
- SST $2.90
- 52 Week High
- LGVN $6.40
- SST $15.70
- Technical
- Relative Strength Index (RSI)
- LGVN 51.52
- SST 51.31
- Support Level
- LGVN $1.27
- SST $4.96
- Resistance Level
- LGVN $1.40
- SST $15.00
- Average True Range (ATR)
- LGVN 0.09
- SST 2.17
- MACD
- LGVN 0.01
- SST -0.18
- Stochastic Oscillator
- LGVN 50.00
- SST 21.07
About LGVN Longeveron Inc.
Longeveron Inc is a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs for specific aging-related and life-threatening conditions. Its investigational product is Lomecel-B an stem cell formulation sourced from the bone marrow of young, healthy adult donors and has potential mechanisms of action that can promote tissue repair and healing. The company currently has three pipeline indications: Hypoplastic Left Heart Syndrome (HLHS), Alzheimer's disease (AD) and Aging-related Frailty.
About SST System1 Inc.
System1 Inc develops technology and data science to operate a responsive acquisition marketing platform. It serves customers in the areas of health and wellness, automotive, finance, travel, and entertainment. The company's segment includes Owned and Operated Advertising (O&O); and Partner Network. It generates maximum revenue from the Owned and Operated Advertising (O&O) segment. Geographically, it operates in United States and Other countries.